Concepedia

Daniel Mrak

DM

14

Publications

633

Citations

12

H-Index

2020

Active since

Affiliations

Medical University of Vienna(Current)

Klinik Hietzing

Hanusch Hospital

Sigmund Freud Privatuniversität Wien

Daniel Mrak is an author at Medical University of Vienna specializing in vaccine development, medicine, and vaccine safety.

ORCID

Top concepts

Publications per year

2020–2024

14

Publications

14

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Daniel Mrak, Selma Tobudic, Maximilian Koblischke et al. · Annals of the Rheumatic Diseases · 2021 · 244 citations

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial

Michael Bonelli, Helga Radner, Andreas Kerschbaumer et al. · Annals of the Rheumatic Diseases · 2022 · 92 citations

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial

Michael Bonelli, Daniel Mrak, Selma Tobudic et al. · Annals of the Rheumatic Diseases · 2022 · 60 citations

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Felix Kartnig, Daniel Mrak, Elisabeth Simader et al. · Annals of the Rheumatic Diseases · 2022 · 42 citations

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

Daniel Mrak, Daniela Sieghart, Elisabeth Simader et al. · Nature Communications · 2022 · 33 citations · Full text

, , +16

Rows per page

1–5 of 14